Literature DB >> 29776293

Analysis of circulating tumor DNA: The next paradigm shift in detection and treatment of lung cancer.

David S Schrump1, Julie A Hong2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29776293      PMCID： PMC6334846          DOI： 10.1016/j.jtcvs.2018.01.060

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  8 in total

1.  Circulating tumor DNA: A promising biomarker to guide postoperative treatment and surveillance of non-small cell lung cancer.

Authors:  James M Isbell; David R Jones; Bob T Li
Journal:  J Thorac Cardiovasc Surg       Date:  2018-03-13       Impact factor: 5.209

2.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

Review 3.  Precision Therapy for Lung Cancer: Tyrosine Kinase Inhibitors and Beyond.

Authors:  Arun Rajan; David S Schrump
Journal:  Semin Thorac Cardiovasc Surg       Date:  2015-04-08

Review 4.  Immune checkpoint inhibitors in advanced non-small cell lung cancer.

Authors:  Hazem I Assi; Alice O Kamphorst; Nour M Moukalled; Suresh S Ramalingam
Journal:  Cancer       Date:  2017-12-06       Impact factor: 6.860

5.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Authors:  Thomas J Lynch; Daphne W Bell; Raffaella Sordella; Sarada Gurubhagavatula; Ross A Okimoto; Brian W Brannigan; Patricia L Harris; Sara M Haserlat; Jeffrey G Supko; Frank G Haluska; David N Louis; David C Christiani; Jeff Settleman; Daniel A Haber
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

6.  Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.

Authors:  Aadel A Chaudhuri; Jacob J Chabon; Alexander F Lovejoy; Aaron M Newman; Henning Stehr; Tej D Azad; Michael S Khodadoust; Mohammad Shahrokh Esfahani; Chih Long Liu; Li Zhou; Florian Scherer; David M Kurtz; Carmen Say; Justin N Carter; David J Merriott; Jonathan C Dudley; Michael S Binkley; Leslie Modlin; Sukhmani K Padda; Michael F Gensheimer; Robert B West; Joseph B Shrager; Joel W Neal; Heather A Wakelee; Billy W Loo; Ash A Alizadeh; Maximilian Diehn
Journal:  Cancer Discov       Date:  2017-09-24       Impact factor: 39.397

7.  Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA.

Authors:  Sarah B Goldberg; Azeet Narayan; Adam J Kole; Roy H Decker; Jimmitti Teysir; Nicholas J Carriero; Angela Lee; Roxanne Nemati; Sameer K Nath; Shrikant M Mane; Yanhong Deng; Nitin Sukumar; Daniel Zelterman; Daniel J Boffa; Katerina Politi; Scott N Gettinger; Lynn D Wilson; Roy S Herbst; Abhijit A Patel
Journal:  Clin Cancer Res       Date:  2018-01-12       Impact factor: 12.531

8.  Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.

Authors:  Christopher Abbosh; Nicolai J Birkbak; Gareth A Wilson; Mariam Jamal-Hanjani; Tudor Constantin; Raheleh Salari; John Le Quesne; David A Moore; Selvaraju Veeriah; Rachel Rosenthal; Teresa Marafioti; Eser Kirkizlar; Thomas B K Watkins; Nicholas McGranahan; Sophia Ward; Luke Martinson; Joan Riley; Francesco Fraioli; Maise Al Bakir; Eva Grönroos; Francisco Zambrana; Raymondo Endozo; Wenya Linda Bi; Fiona M Fennessy; Nicole Sponer; Diana Johnson; Joanne Laycock; Seema Shafi; Justyna Czyzewska-Khan; Andrew Rowan; Tim Chambers; Nik Matthews; Samra Turajlic; Crispin Hiley; Siow Ming Lee; Martin D Forster; Tanya Ahmad; Mary Falzon; Elaine Borg; David Lawrence; Martin Hayward; Shyam Kolvekar; Nikolaos Panagiotopoulos; Sam M Janes; Ricky Thakrar; Asia Ahmed; Fiona Blackhall; Yvonne Summers; Dina Hafez; Ashwini Naik; Apratim Ganguly; Stephanie Kareht; Rajesh Shah; Leena Joseph; Anne Marie Quinn; Phil A Crosbie; Babu Naidu; Gary Middleton; Gerald Langman; Simon Trotter; Marianne Nicolson; Hardy Remmen; Keith Kerr; Mahendran Chetty; Lesley Gomersall; Dean A Fennell; Apostolos Nakas; Sridhar Rathinam; Girija Anand; Sajid Khan; Peter Russell; Veni Ezhil; Babikir Ismail; Melanie Irvin-Sellers; Vineet Prakash; Jason F Lester; Malgorzata Kornaszewska; Richard Attanoos; Haydn Adams; Helen Davies; Dahmane Oukrif; Ayse U Akarca; John A Hartley; Helen L Lowe; Sara Lock; Natasha Iles; Harriet Bell; Yenting Ngai; Greg Elgar; Zoltan Szallasi; Roland F Schwarz; Javier Herrero; Aengus Stewart; Sergio A Quezada; Karl S Peggs; Peter Van Loo; Caroline Dive; C Jimmy Lin; Matthew Rabinowitz; Hugo J W L Aerts; Allan Hackshaw; Jacqui A Shaw; Bernhard G Zimmermann; Charles Swanton
Journal:  Nature       Date:  2017-04-26       Impact factor: 49.962
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.